UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
25.28%
↓ 36% below average
Average (9y)
39.22%
Historical baseline
Range
High:162.35%
Low:-13.78%
CAGR
-18.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 25.28% |
| 2023 | -13.78% |
| 2022 | 11.05% |
| 2021 | 0.70% |
| 2020 | -4.03% |
| 2019 | 33.47% |
| 2018 | 97.54% |
| 2017 | 81.75% |
| 2016 | -2.17% |
| 2015 | 162.35% |